Breaking News Instant updates and real-time market news.

WSM

Williams-Sonoma

$51.69

(0.00%)

, CSX

CSX

$75.00

(0.00%)

09:40
05/31/19
05/31
09:40
05/31/19
09:40

Unusually active option classes on open May 31st

Unusual total active option classes on open include: Williams Sonoma (WSM), CSX (CSX), EWW (EWW), Costco (COST), Ulta Beauty (ULTA), Zscaler (ZS), Uber (UBER), Direxion Junior Gold (JNUG), Direxion Daily Gold Miners Bull 3X Shares (NUGT), and General Motors (GM).

WSM

Williams-Sonoma

$51.69

(0.00%)

CSX

CSX

$75.00

(0.00%)

EWW

iShares MSCI Mexico

$44.57

(0.00%)

COST

Costco

$241.50

(0.00%)

ULTA

Ulta Beauty

$328.21

(0.00%)

ZS

Zscaler

$72.94

(0.00%)

UBER

Uber

$39.76

(0.00%)

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$6.78

(0.00%)

NUGT

Direxion Gold Miners Bull

$15.20

(0.00%)

GM

General Motors

$34.83

(0.00%)

  • 04

    Jun

  • 05

    Jun

  • 05

    Jun

  • 05

    Jun

  • 05

    Jun

  • 10

    Jun

  • 18

    Jun

  • 10

    Jul

  • 01

    Aug

  • 29

    Aug

  • 03

    Oct

  • 13

    Nov

WSM Williams-Sonoma
$51.69

(0.00%)

05/10/19
BREN
05/10/19
INITIATION
Target $61
BREN
Hold
Williams-Sonoma initiated with a Hold at Berenberg
Berenberg analyst Sumit Sharma started Williams-Sonoma with a Hold rating and $61 price target.
03/20/19
EVER
03/20/19
INITIATION
Target $60
EVER
In Line
Williams-Sonoma initiated with an In Line at Evercore ISI
Evercore ISI analyst Oliver Wintermantel started Williams-Sonoma with an In Line rating and $60 base case price target, stating that the company has made very good progress in transforming into a true multichannel retailer. However, the current multiple assumes further profitability declines, as does his model.
03/21/19
RBCM
03/21/19
NO CHANGE
Target $60
RBCM
Sector Perform
Williams-Sonoma price target raised to $60 from $54 at RBC Capital
RBC Capital analyst Scot Ciccarelli raised his price target on Williams-Sonoma to $60 after its "solid" Q4 earnings beat that was "heavily" driven by its favorable tax rate. The analyst is also keeping his Sector Perform rating on the shares, stating that in spite of the latest results and modest valuation, he remains concerned with the company's longer-term margin profile as "competitive pricing and free shipping pressures" will likely chip away at margins over time.
03/21/19
MSCO
03/21/19
NO CHANGE
Target $49
MSCO
Underweight
Williams-Sonoma 2019 guidance 'seemingly optimistic,' says Morgan Stanley
Morgan Stanley analyst Simeon Gutman called Williams-Sonoma's Q4 earnings beat "low quality," noting that it was driven by a reversal of one-time charges despite comparable store sales and gross margins that missed expectations. He also thinks the company offered "seemingly optimistic" 2019 guidance, as he believes it will be difficult for Williams-Sonoma to generate 2-5% comp growth and flat EBIT margins in 2019 given that he expects same-store growth at the Pottery Barn and its flagship brand to decelerate and serve as a drag on overall top-line growth. Gutman keeps an Underweight rating and $49 price target on the stock.
CSX CSX
$75.00

(0.00%)

04/17/19
BMOC
04/17/19
NO CHANGE
Target $78
BMOC
Market Perform
CSX price target raised to $78 from $76 at BMO Capital
BMO Capital analyst Fadi Chamoun raised his price target on CSX to $78 after its "modestly better than expected" Q1 results, even when excluding "contribution from one-time items". The analyst notes that until now, CSX has been an "efficiency improvement with strong execution" story, but believes that "materially improved" service levels could generate volume growth and sustain the company's strong earnings momentum over the medium term. Chamoun is keeping his Market Perform rating on CSX stock to reflect its "balanced valuation" and his cautious macro view.
04/17/19
FBCO
04/17/19
NO CHANGE
Target $93
FBCO
Outperform
CSX price target raised to $93 from $88 at Credit Suisse
Credit Suisse analyst Allison Landry raised her price target for CSX to $93 from $88, while reiterating an Outperform rating on the shares. While there were a couple of transitory items that helped in the quarter, the analyst believes they do not at all detract from the otherwise compelling long term story at CSX that the Q1 results are underwriting, namely that the company continues to execute on meaningful structural cost take-outs, a higher quality revenue stream, and improved free cash flow conversion.
04/17/19
SBSH
04/17/19
NO CHANGE
Target $86
SBSH
Buy
CSX shares should move toward $86 as estimates rise, says Citi
Citi analyst Christian Wetherbee sees estimates moving higher and shares of CSX moving towards his $86 price target following the company's Q1 results. CSX's operating ratio improved sequentially "against typically strongly negative seasonality," leading to results which were "solidly better" than expected, Wetherbee tells investors in a post-earnings research note. He thinks the company's report will be viewed favorably across rails as a strong start to 2019. The analyst keeps a Buy rating on CSX.
04/05/19
UBSW
04/05/19
DOWNGRADE
Target $80
UBSW
Neutral
CSX downgraded to Neutral from Buy at UBS
UBS analyst Thomas Wadewitz downgraded CSX to Neutral from Buy while raising his price target for the shares to $80 from $75. The stock, after performing strongly on a multi-year basis and also in 2019, now reflects the good news in terms of further margin improvement and "industry leading" operating ratio performance, Wadewitz tells investors in a research note. The analyst believes CSX's reward/risk is no longer skewed to the upside at current share levels.
EWW iShares MSCI Mexico
$44.57

(0.00%)

COST Costco
$241.50

(0.00%)

05/31/19
BARD
05/31/19
NO CHANGE
Target $270
BARD
Outperform
Costco bull thesis remains intact, says Baird
Baird analyst Peter Benedict noted Costco reported better than expected Q3 results. He believes the company's expanding structural cost advantages, approach to passing savings on to members, and growing omni-channel capabilities, are driving increased relevance with consumers. With still meaningful long-term growth opportunities ahead, he remains a buyer of the shares. Benedict reiterated his Outperform rating and $270 price target on Costco shares.
05/29/19
05/29/19
DOWNGRADE

Hold
Costco downgraded to Hold on valuation at Gordon Haskett
As previously reported, Gordon Haskett downgraded Costco to Hold from Accumulate with a $255 price target. Analyst Chuck Grom said this is not a call on the quarter, but feels it is prudent to reduce exposure following strong year-to-date stock performance.
05/29/19
GDHS
05/29/19
DOWNGRADE
GDHS
Hold
Costco downgraded to Hold from Accumulate at Gordon Haskett
Gordon Haskett analyst Chuck Grom downgraded Costco Wholesale to Hold from Accumulate saying the stock's near-term risk/reward is not compelling.
05/23/19
BARD
05/23/19
NO CHANGE
Target $270
BARD
Outperform
Baird recommends 'continued accumulation' of Costco ahead of earnings
Baird analyst Peter Benedict kept his Outperform rating and $270 price target on Costco ahead of its Q3 earnings, saying that the unfavorable gas margin dynamics in the quarter have put his expected EPS of $1.77 below the consensus $1.82 level. The analyst adds that while Costco's core comps may have moderated, its top line trends continue to outperform in the retail sector while its better renewal rates validate its strategy to invest for loyalty. In spite of the valuation on Costco rising above its historical trend, Benedict urges investors to continue accumulating this "growth staple" stock.
ULTA Ulta Beauty
$328.21

(0.00%)

05/14/19
GUGG
05/14/19
NO CHANGE
Target $375
GUGG
Buy
Ulta Beauty price target raised to $375 from $350 at Guggenheim
Guggenheim analyst Steven Forbes raised his price target for Ulta Beauty to $375 from $350 and reiterates a Buy rating on the shares. After reviewing Euromonitor's 2019 Beauty and Personal Care report and market data, the analyst has increased confidence in Ulta's ability to meet or exceed consensus revenue estimates through 2020. Moderated market share expectations, especially within cosmetics, coupled with above-trend growth in skin care and hair care, should drive share price outperformance for Ulta Beauty in 2019, Forbes tells investors in a research note.
05/14/19
COWN
05/14/19
NO CHANGE
COWN
Tariffs to yield major EPS cuts, higher customer prices, says Cowen
Amid the U.S./China trade battle, Cowen analyst Oliver Chen says negative EPS impact could be (10%-(30%) or worse as retailers are unlikely to be able to pass on all of potential cost of goods sold increases. The analyst believes the best positioned Outperform rated stocks are Planet Fitness (PLNT), Walmart (WMT), Ulta Beauty (ULTA), LVMH (LVMUY), and Costco (COST) as these have lower China sourcing risk and greater scale. He sees the most potential vulnerability at apparel and department store retailers. Further, Chen believes that consumers could experience price increases by as much as 10%-15% across impacted categories, which would yield up to $100B or more of incremental cost to consumers, depending on the breadth and depth of goods impacted. These factors are likely to impact supply/demand planning for back to school and holiday, he contends.
05/31/19
OPCO
05/31/19
NO CHANGE
Target $370
OPCO
Outperform
Ulta Beauty price target lowered to $370 from $400 at Oppenheimer
Oppenheimer analyst Rupesh Parikh lowered his price target for Ulta Beauty to $370 from $400 while maintaining an Outperform rating following the company's Q1 results, saying he overall looks "favorable" on the report. In a research note to investors, Parikh says he would take advantage of Ulta trading in the sub-$320 level after market. Ulta's efforts continue to drive meaningful share gains lately and have required less gross margin investment suggesting a much healthier level of growth, but says he lowered his price target given a more difficult beauty backdrop and retail re-rating lately.
05/31/19
BARD
05/31/19
NO CHANGE
Target $395
BARD
Outperform
Ulta Beauty remains on track to meet/exceed growth targets, says Baird
Baird analyst Mark Altschwager said Ulta Beauty delivered a solid start to the year with comps at the high end of annual guidance ranges, healthy incremental gross margins, and good flow-through. The analyst said he continues to like the risk/reward as he believes Ulta has a durable, share-winning, best in class model. Altschwager reiterated his Outperform rating and $395 price target on Ulta Beauty shares.
ZS Zscaler
$72.94

(0.00%)

05/31/19
BREN
05/31/19
INITIATION
Target $78
BREN
Hold
Zscaler initiated with a Hold at Berenberg
Berenberg analyst Joshua Tilton started Zscaler with a Hold rating and $78 price target, stating that the company's "disruptive" product provides a true cloud alternative to a number of legacy security vendors, but he sees the valuation as having crossed the line for a "reasonable" or "justifiable" multiple.
05/31/19
BARD
05/31/19
NO CHANGE
Target $80
BARD
Outperform
Zscaler price target raised to $80 from $65 at Baird
Baird analyst Jonathan Ruykhaver raised his price target on Zscaler to $80 from $65 following strong Q3 results. The analyst cited its Q4 guidance, backlog growth, and high net retention. Ruykhaver reiterated his Outperform rating on Zscaler shares.
05/31/19
NEED
05/31/19
NO CHANGE
Target $89
NEED
Strong Buy
Zscaler price target raised to $89 from $65 at Needham
Needham analyst Alex Henderson raised his price target on Zscaler to $89 and kept his Strong Buy rating after its "exceptionally strong" Q3 results that showed revenue growth of 61 and billings growth of 55% along with "sharp" margin improvement in spite of the management's focus on growth over margins. The analyst is positive on the company's execution and technology adoption dynamics, with broader deal size and platform adoption driving its performance. Henderson adds that the company has no "meaningful competition" and offers "unique" capabilities in the market.
05/31/19
PIPR
05/31/19
NO CHANGE
Target $82
PIPR
Overweight
Zscaler price target raised to $82 from $65 at Piper Jaffray
Piper Jaffray analyst Andrew Nowinski raised his price target for Zscaler to $82 from $65 saying the company reported "solid" fiscal Q3 results, with revenue exceeding the high-end of guidance by 5.5%. Billings exceeded consensus by 17%, though the stock was trading down in after-hours, likely on concerns around the Q4 guidance, Nowinski tells investors in a research note. The analyst believes Zscaler's momentum is growing and he reiterates an Overweight rating on the shares. He notes that the company had a $16.5M deal in the prior year period and after excluding this large deal, billing guidance for Q4 equates to 46.8% year-over-year growth.
UBER Uber
$39.76

(0.00%)

05/31/19
DADA
05/31/19
NO CHANGE
Target $46
DADA
Neutral
Uber price target lowered to $46 from $53 at DA Davidson
DA Davidson analyst Tom White lowered his price target on Uber (UBER) to $46 and kept his Neutral rating after its Q1 results revealed "few surprises". The analyst notes that although the management was more positive on moderating competition, as Uber and Lyft (LYFT) start to compete "more around brand and product" rather than price, he does not expect major changes in the buy-side estimates on the stock. White notes that his new price target assumes a "more conservative" 4.1-time multiple on enterprise value relative to his expected FY20 sales.
05/31/19
JPMS
05/31/19
NO CHANGE
Target $86
JPMS
Overweight
JPMorgan says buy Lyft as shares offer 50% potential upside
After hosting investor meetings with management, JPMorgan analyst Doug Anmuth recommends buying shares of Lyft (LYFT) on the "increasingly rational" ridesharing industry as well as the company's improving profitability. Management's overall tone was very confident around the easing of the competitive environment in U.S. ridesharing, core ridesharing losses improving, ongoing leverage in insurance costs, and the "high-growth, high-margin" revenue opportunities in Lyft Business, Anmuth tells investors in a research note. Further and importantly, on its earnings call last night, Uber (UBER) echoed Lyft's comments on the more favorable operating environment in the U.S., adds the analyst. He keeps an Overweight rating on Lyft with an $86 price target, suggesting 50% potential upside. The stock closed yesterday down $1.43 to $54.83.
05/31/19
ATLE
05/31/19
UPGRADE
Target $52
ATLE
Overweight
Atlantic upgrades Uber on 'increasingly benign' competitive environment
Atlantic Equities analyst James Cordwell upgraded Uber Technologies to Overweight from Neutral while lowering his price target for the shares to $52 from $55. The stock closed yesterday down 14c to $39.80. The ridehailing competitive environment is becoming "increasingly benign" while Uber shares have become more attractively valued, Cordwell tells investors in a research note. The analyst expects a better competitive environment to drive accelerating revenue growth and moderating segment losses across fiscal 2019. Further, a new Uber Eats fee structure should augment the company's food delivery economics while enabling "rapid" bookings growth, Cordwell tells investors in a research note.
05/31/19
WEDB
05/31/19
NO CHANGE
Target $65
WEDB
Outperform
Uber's Q1 'an important step,' says Wedbush
Wedbush analyst Ygal Arounian reiterated an Outperform rating and $65 price target on Uber following the comany's Q1 results, saying the report was an "important step" for the company as investors needed a bridge between near-term headwinds and the long-term vision working. Additionally, Arounian says he feels that the results addressed many concerns investors had been seeking clarity on, despite not giving revenue or EBITDA guidance for the full year.
JNUG Direxion Daily Jr Gld Mnrs Bull 3X Shrs
$6.78

(0.00%)

NUGT Direxion Gold Miners Bull
$15.20

(0.00%)

GM General Motors
$34.83

(0.00%)

05/02/19
NOMU
05/02/19
NO CHANGE
Target $42
NOMU
Neutral
General Motors price target raised to $42 from $36 at Nomura Instinet
Nomura Instinet analyst Anindya Das raised his price target for General Motors to $42 from $36 while keeping a Neutral rating on the shares. In 2019, the analyst expects GM North America to benefit from the extended rollout of the next-generation full-size pickups. However, he sees these gains being partly offset by stiffer competition in the mid-size pickup segment, pricing headwinds for full-size pickups, and volume headwinds from GM's partial withdrawal from the passenger car segment.
05/15/19
05/15/19
NO CHANGE

Trump plans to delay imposing tariffs on auto imports, Bloomberg reports
Publicly traded companies in the space include Daimler AG (DDAIF), Fiat Chrysler (FCAU), Ford (F), General Motors (GM), Honda (HMC), Nissan (NSANY), Toyota (TM), Volkswagen (VWAGY) and Tesla (TLSA).
05/15/19
MSCO
05/15/19
NO CHANGE
MSCO
Tariff delay a 'modest positive' for automakers, says Morgan Stanley
Morgan Stanley analyst Michael Zezas called media reports indicating that the U.S. plans to delay auto tariffs by up to 6 months a "modest positive" for the automaking group, stating that extra time somewhat reduces the probability of tariffs going into place but that the core impasse between the U.S. and EU - namely whether or not to include agricultural issues in negotiations - still remains and is the real driver of the tariff tension. The analyst, who noted that the U.S. retains the option to implement tariffs at any point within the 180 day delay, said he still thinks auto tariffs are likely to go into effect later this year. Publicly traded automakers that moved up following the headlines regarding the delay decision include Daimler AG (DDAIF), Fiat Chrysler (FCAU), Ford (F), General Motors (GM), Honda (HMC), Nissan (NSANY), Toyota (TM) and Volkswagen (VWAGY).
05/01/19
MSCO
05/01/19
NO CHANGE
Target $44
MSCO
Overweight
Morgan Stanley 'sympathetic' to some GM profit taking, keeps Overweight rating
Morgan Stanley analyst Adam Jonas said General Motors' (GM) core Q1 results were "broadly in line" after stripping away the mark-to-market "noise" from the Lyft (LYFT) and PSA revaluations and other factors and he does not see the report materially changing the GM story. While he keeps an Overweight rating on GM shares with a $44 price target, Jonas said he is "sympathetic to some investor profit taking" following the recent run in the stock.

TODAY'S FREE FLY STORIES

AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

, GRUB

GrubHub

$70.15

-2.76 (-3.79%)

13:28
06/15/19
06/15
13:28
06/15/19
13:28
Periodicals
Amazon exit gives GrubHub stock boost, Barron's says »

Amazon (AMZN) is…

AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

GRUB

GrubHub

$70.15

-2.76 (-3.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 10

    Jul

ABC

AmerisourceBergen

$85.01

-1.46 (-1.69%)

, CAH

Cardinal Health

$44.16

-1.13 (-2.50%)

13:20
06/15/19
06/15
13:20
06/15/19
13:20
Periodicals
McKesson, Cardinal Health looking like bargains, Barron's says »

Investors have halved the…

ABC

AmerisourceBergen

$85.01

-1.46 (-1.69%)

CAH

Cardinal Health

$44.16

-1.13 (-2.50%)

MCK

McKesson

$133.19

-1.7 (-1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

RTN

Raytheon

$177.38

0.195 (0.11%)

, UTX

United Technologies

$125.30

0.45 (0.36%)

13:09
06/15/19
06/15
13:09
06/15/19
13:09
Periodicals
United Technologies, Raytheon stocks looking cheap, Barron's says »

Shares of United…

RTN

Raytheon

$177.38

0.195 (0.11%)

UTX

United Technologies

$125.30

0.45 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 17

    Jun

  • 17

    Jun

GRUB

GrubHub

$70.15

-2.76 (-3.79%)

, AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

13:04
06/15/19
06/15
13:04
06/15/19
13:04
Periodicals
Food fight extending well beyond restaurant delivery, Barron's says »

Amazon (AMZN) is quitting…

GRUB

GrubHub

$70.15

-2.76 (-3.79%)

AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 10

    Jul

GOOGL

Alphabet Class A

$1,086.36

-4.65 (-0.43%)

, GOOG

Alphabet

$1,085.56

-3.52 (-0.32%)

12:59
06/15/19
06/15
12:59
06/15/19
12:59
Periodicals
Facebook, JPMorgan chiefs among Best CEOs of 2019, Barron's says »

Separated into three…

GOOGL

Alphabet Class A

$1,086.36

-4.65 (-0.43%)

GOOG

Alphabet

$1,085.56

-3.52 (-0.32%)

FB

Facebook

$181.35

3.88 (2.19%)

MCD

McDonald's

$205.33

0.85 (0.42%)

JPM

JPMorgan

$109.84

0.26 (0.24%)

BAC

Bank of America

$28.03

0.09 (0.32%)

BLK

BlackRock

$446.96

-1.29 (-0.29%)

BX

Blackstone

$44.13

0.17 (0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 19

    Jun

  • 09

    Jul

  • 10

    Jul

  • 16

    Jul

  • 17

    Jul

  • 06

    Aug

  • 27

    Oct

AVGO

Broadcom

$265.99

-15.96 (-5.66%)

, AAPL

Apple

$192.84

-1.93 (-0.99%)

07:17
06/15/19
06/15
07:17
06/15/19
07:17
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AVGO

Broadcom

$265.99

-15.96 (-5.66%)

AAPL

Apple

$192.84

-1.93 (-0.99%)

HNHPF

Hon Hai Precision

$0.00

(0.00%)

UTX

United Technologies

$125.30

0.45 (0.36%)

RTN

Raytheon

$177.38

0.195 (0.11%)

CGC

Canopy Growth

$41.15

-0.64 (-1.53%)

TLRY

Tilray

$38.96

-1.78 (-4.37%)

APHA

Aphria

$6.80

-0.15 (-2.16%)

ACB

Aurora Cannabis

$7.56

(0.00%)

CVSI

CV Sciences

$0.00

(0.00%)

CNTTF

CannTrust Holdings

$0.00

(0.00%)

CRON

Cronos Group

$15.43

-0.92 (-5.63%)

CANN

General Cannabis

$0.00

(0.00%)

IGC

India Globalization Capital

$1.28

0.4201 (48.85%)

MLCPF

MediPharm Labs

$0.00

(0.00%)

ZYNE

Zynerba

$13.03

-0.54 (-3.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 17

    Jun

  • 17

    Jun

  • 18

    Jun

  • 19

    Jun

  • 21

    Jun

  • 25

    Jun

  • 09

    Jul

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

, ABMD

Abiomed

$250.96

-4.58 (-1.79%)

04:55
06/15/19
06/15
04:55
06/15/19
04:55
Conference/Events
International League of Dermatological Societies to hold a conference »

24th World Congress of…

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

ABMD

Abiomed

$250.96

-4.58 (-1.79%)

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

CELG

Celgene

$96.49

0.07 (0.07%)

LLY

Eli Lilly

$111.74

-0.06 (-0.05%)

JNJ

Johnson & Johnson

$140.08

-0.63 (-0.45%)

NVS

Novartis

$89.52

-0.07 (-0.08%)

PFE

Pfizer

$42.75

0.24 (0.56%)

PG

Procter & Gamble

$111.20

0.28 (0.25%)

SNY

Sanofi

$42.46

-0.225 (-0.53%)

UL

Unilever; also tag UN

$62.61

-0.07 (-0.11%)

UN

Unilever; also tag UL

$61.30

-0.13 (-0.21%)

INCY

Incyte

$77.76

1.385 (1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 17

    Jun

  • 26

    Jun

  • 27

    Jun

  • 16

    Jul

  • 25

    Jul

  • 30

    Jul

  • 28

    Aug

  • 03

    Sep

  • 16

    Sep

  • 13

    Nov

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

, GSK

GlaxoSmithKline

$40.12

0.015 (0.04%)

04:55
06/15/19
06/15
04:55
06/15/19
04:55
Conference/Events
European Congress of Rheumatology to hold a conference »

EULAR 2019 will be held…

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

GSK

GlaxoSmithKline

$40.12

0.015 (0.04%)

PFE

Pfizer

$42.75

0.24 (0.56%)

LLY

Eli Lilly

$111.74

-0.06 (-0.05%)

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

NVS

Novartis

$89.52

-0.07 (-0.08%)

RHHBY

Roche

$0.00

(0.00%)

BIIB

Biogen

$227.67

-3.57 (-1.54%)

AMGN

Amgen

$176.09

-0.74 (-0.42%)

SNY

Sanofi

$42.46

-0.225 (-0.53%)

CELG

Celgene

$96.49

0.07 (0.07%)

GILD

Gilead

$66.38

-0.62 (-0.93%)

REGN

Regeneron

$305.19

-2.235 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 25

    Jul

  • 30

    Jul

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 26

    Aug

  • 28

    Aug

  • 29

    Aug

  • 02

    Sep

  • 03

    Sep

  • 16

    Sep

  • 04

    Nov

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

ABT

Abbott

$82.25

-0.03 (-0.04%)

, AMGN

Amgen

$176.09

-0.74 (-0.42%)

04:55
06/15/19
06/15
04:55
06/15/19
04:55
Conference/Events
Society for Vascular Surgery to hold annual meeting »

SVS Annual Meeting 2019…

ABT

Abbott

$82.25

-0.03 (-0.04%)

AMGN

Amgen

$176.09

-0.74 (-0.42%)

BSX

Boston Scientific

$40.41

-0.26 (-0.64%)

PFE

Pfizer

$42.75

0.24 (0.56%)

CRY

CryoLife

$29.13

-0.13 (-0.44%)

EW

Edwards Lifesciences

$184.00

-0.63 (-0.34%)

ELGX

Endologix

$7.61

0.2 (2.70%)

IAC

IAC

$228.41

-2.63 (-1.14%)

HCA

HCA Healthcare

$126.64

-0.76 (-0.60%)

LMAT

LeMaitre

$26.04

-0.44 (-1.66%)

ORGO

Organogenesis

$7.39

0.02 (0.27%)

OSIR

Osiris

$0.00

(0.00%)

PEN

Penumbra

$166.75

2.93 (1.79%)

SWAV

ShockWave Medical

$58.27

-0.99 (-1.67%)

WTKWY

Wolters Kluwer

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 26

    Jun

  • 09

    Aug

  • 26

    Aug

  • 26

    Aug

  • 28

    Aug

  • 16

    Sep

  • 25

    Sep

  • 13

    Nov

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

, INCY

Incyte

$77.76

1.385 (1.81%)

04:55
06/15/19
06/15
04:55
06/15/19
04:55
Conference/Events
European Hematology Association to hold a conference »

24th EHA Congress 2019…

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

INCY

Incyte

$77.76

1.385 (1.81%)

ARQL

ArQule

$8.17

1.88 (29.89%)

AMGN

Amgen

$176.09

-0.74 (-0.42%)

ALXN

Alexion

$117.94

0.65 (0.55%)

AGIO

Agios Pharmaceuticals

$47.97

-1.78 (-3.58%)

AZN

AstraZeneca

$39.68

-0.23 (-0.58%)

BLUE

Bluebird Bio

$117.57

-6.33 (-5.11%)

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

CELG

Celgene

$96.49

0.07 (0.07%)

NVS

Novartis

$89.52

-0.07 (-0.08%)

NSTG

NanoString

$25.96

0.45 (1.76%)

KPTI

Karyopharm

$5.71

-0.04 (-0.70%)

JAZZ

Jazz Pharmaceuticals

$130.43

0.28 (0.22%)

GSK

GlaxoSmithKline

$40.12

0.015 (0.04%)

GILD

Gilead

$66.38

-0.62 (-0.93%)

DSNKY

Daiichi Sankyo

$0.00

(0.00%)

PFE

Pfizer

$42.75

0.24 (0.56%)

PTLA

Portola Pharmaceuticals

$25.78

-0.31 (-1.19%)

QGEN

Qiagen

$39.52

-0.07 (-0.18%)

RHHBY

Roche

$0.00

(0.00%)

RIGL

Rigel Pharmaceuticals

$2.06

-0.06 (-2.83%)

SNY

Sanofi

$42.46

-0.225 (-0.53%)

SGEN

Seattle Genetics

$68.67

-0.33 (-0.48%)

STML

Stemline

$14.20

0.12 (0.85%)

VSTM

Verastem

$1.39

0.125 (9.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jun

  • 17

    Jun

  • 18

    Jun

  • 20

    Jun

  • 20

    Jun

  • 20

    Jun

  • 21

    Jun

  • 23

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 28

    Jun

  • 06

    Jul

  • 25

    Jul

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 26

    Aug

  • 28

    Aug

  • 29

    Aug

  • 02

    Sep

  • 03

    Sep

  • 16

    Sep

  • 04

    Nov

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

CNC

Centene

$53.52

-0.26 (-0.48%)

, WCG

WellCare

$287.16

0.145 (0.05%)

18:45
06/14/19
06/14
18:45
06/14/19
18:45
Hot Stocks
Centene CEO: Medicare for all will not work »

In an interview on…

CNC

Centene

$53.52

-0.26 (-0.48%)

WCG

WellCare

$287.16

0.145 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 23

    Jul

HMC

Honda

$25.34

-0.405 (-1.57%)

18:24
06/14/19
06/14
18:24
06/14/19
18:24
Hot Stocks
Honda recalls all 2016-2019 model year Pioneer vehicles »

Honda is conducting a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RH

RH

$111.28

1.42 (1.29%)

18:22
06/14/19
06/14
18:22
06/14/19
18:22
Hot Stocks
RH CEO: We think our stock is massively undervalued »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DISH

Dish

$37.54

-0.35 (-0.92%)

, S

Sprint

$7.01

0.2 (2.94%)

18:08
06/14/19
06/14
18:08
06/14/19
18:08
Periodicals
Dish leads bidding for Sprint, T-Mobile assets, WSJ reports »

Dish Network (DISH) is…

DISH

Dish

$37.54

-0.35 (-0.92%)

S

Sprint

$7.01

0.2 (2.94%)

TMUS

T-Mobile

$74.90

0.44 (0.59%)

CHTR

Charter

$392.20

2.76 (0.71%)

ATUS

Altice USA

$23.82

0.15 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAL

American Airlines

$32.69

-0.39 (-1.18%)

17:31
06/14/19
06/14
17:31
06/14/19
17:31
Periodicals
American Air asks court to end 'devastating' work slowdown, Bloomberg says »

American Airlines urged a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROLL

RBC Bearings

$150.43

-3.38 (-2.20%)

17:16
06/14/19
06/14
17:16
06/14/19
17:16
Hot Stocks
RBC Bearings CEO sells over 5,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTNW

FTE Networks

$1.25

(0.00%)

17:14
06/14/19
06/14
17:14
06/14/19
17:14
Hot Stocks
FTE Networks granted financial viability exception by NYSE regulation »

FTE Networks announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$347.19

-1.54 (-0.44%)

17:14
06/14/19
06/14
17:14
06/14/19
17:14
Hot Stocks
Boeing awarded Air Force contract modification, increases ceiling by $6.53B »

Boeing has been awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 09

    Jul

MDR

McDermott

$7.60

-0.12 (-1.55%)

17:11
06/14/19
06/14
17:11
06/14/19
17:11
Hot Stocks
Chatterjee Fund Management reports 5.6% passive stake in McDermott »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PZZA

Papa John's

$50.74

0.28 (0.55%)

17:09
06/14/19
06/14
17:09
06/14/19
17:09
Hot Stocks
Papa John's dismisses KPMG as auditors, hires Ernst & Young »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 20

    Jun

  • 20

    Jun

  • 13

    Nov

EPZM

Epizyme

$11.62

-0.36 (-3.01%)

16:55
06/14/19
06/14
16:55
06/14/19
16:55
Conference/Events
Epizyme to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

CACI

CACI

$202.80

-1.205 (-0.59%)

16:54
06/14/19
06/14
16:54
06/14/19
16:54
Conference/Events
CACI to hold a conference call »

Management holds a fiscal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

HCR

Hi-Crush Inc.

$2.84

0.115 (4.22%)

16:53
06/14/19
06/14
16:53
06/14/19
16:53
Syndicate
Hi-Crush Inc files $1B mixed securities shelf »

The company also files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHIP

Seanergy Marine

$0.63

-0.0381 (-5.70%)

16:51
06/14/19
06/14
16:51
06/14/19
16:51
Earnings
Seanergy Marine reports Q1 EPS ($3.23), two estimates ($2.85) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FELP

Foresight Energy

$0.79

-0.04 (-4.82%)

16:46
06/14/19
06/14
16:46
06/14/19
16:46
Hot Stocks
Foresight Energy discloses NYSE listing standard notice »

Foresight Energy is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.